October 2024. Key learnings include: Key Payer & Provider Market Updates, Inflation Reduction Act - Changes to Part D Benefit Design & Payer Responses, Inflation Reduction Act - Negotiated Drug Prices & Payer Responses, Latest Trends in Payer Medication Management, with an added focus in Oncology, and Maintaining Market Access with Effective Account Engagement & Contracting
HIRC Webinar Series
April 2024. Key learnings include top market trends, updates, and disruptors for 2024, trends in medical benefit management, payer management update in biosimilars, oncology, rare disease, and obesity, and select benchmarking metrics as well as the current contracting environment.
October 2023. Covers critical need-to-know market updates for manufacturers, including updates in regulatory, PBMs, biosimilars, growing & emerging classes, and select HIRC contracting & benchmark data to guide account engagement in 2024.
April 2023. A tour of the top recent headlines paired with a review the latest HIRC data in payer drug management and contracting. Topics include: Continued Drug Pricing Pressures, Growing Regulation of PBMs, Status of and Push-back on Copay Adjustment/Alternative Funding Programs Payer Management, Biosimilars Update, Financing of Rare Disease & Gene Therapy Medications and more!
HIRC Webinar Series
Webinar Topics
The webinar schedule and topics vary based upon to the current health care environment. Research directors and consultants select topics or new data/insights that they feel are critical for manufacturers to be aware of.
Please contact us if you have a particular topic of interest for us to consider for our next webinar. HIRC full-service clients may access full webinar presentation materials and on demand recordings at any time.
Webinar Speakers
Karen Ernst has decades of experience in the health care and pharmaceutical industries, including nearly two decades of conducting research and analysis across HIRC services and providing strategic consulting insights to clients.
Lisa Nanfra has 20+ years experience in the biopharma space as commercial executive leading sales, national account and marketing teams responsible for blockbuster brands. Lisa’s diverse experience has equipped her with a deep understanding of the macro healthcare environment as well as the challenges within it.
